Credit Suisse’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,976
| Closed | -$108K | – | 3513 |
|
2021
Q2 | $108K | Buy |
1,976
+1,491
| +307% | +$81.5K | ﹤0.01% | 3500 |
|
2021
Q1 | $28K | Sell |
485
-93
| -16% | -$5.37K | ﹤0.01% | 3387 |
|
2020
Q4 | $21K | Sell |
578
-23,953
| -98% | -$870K | ﹤0.01% | 3442 |
|
2020
Q3 | $1.32M | Buy |
24,531
+20,444
| +500% | +$1.1M | ﹤0.01% | 2085 |
|
2020
Q2 | $1.03M | Buy |
4,087
+1,962
| +92% | +$494K | ﹤0.01% | 2306 |
|
2020
Q1 | $334K | Buy |
+2,125
| New | +$334K | ﹤0.01% | 2755 |
|
2019
Q4 | – | Sell |
-448
| Closed | -$65K | – | 3485 |
|
2019
Q3 | $65K | Sell |
448
-76
| -15% | -$11K | ﹤0.01% | 3336 |
|
2019
Q2 | $109K | Buy |
524
+54
| +11% | +$11.2K | ﹤0.01% | 3295 |
|
2019
Q1 | $99K | Buy |
+470
| New | +$99K | ﹤0.01% | 3249 |
|
2018
Q4 | – | Sell |
-351
| Closed | -$79K | – | 3329 |
|
2018
Q3 | $79K | Sell |
351
-135
| -28% | -$30.4K | ﹤0.01% | 3247 |
|
2018
Q2 | $73K | Sell |
486
-363
| -43% | -$54.5K | ﹤0.01% | 3403 |
|
2018
Q1 | $156K | Sell |
849
-1,787
| -68% | -$328K | ﹤0.01% | 3309 |
|
2017
Q4 | $562K | Buy |
2,636
+1,670
| +173% | +$356K | ﹤0.01% | 2883 |
|
2017
Q3 | $207K | Buy |
+966
| New | +$207K | ﹤0.01% | 3430 |
|
2017
Q2 | – | Sell |
-633
| Closed | -$157K | – | 3432 |
|
2017
Q1 | $157K | Buy |
+633
| New | +$157K | ﹤0.01% | 3281 |
|